Dynamic Technology Lab Private Ltd Has $841,000 Stock Holdings in Penumbra, Inc. (NYSE:PEN)

Dynamic Technology Lab Private Ltd lifted its holdings in shares of Penumbra, Inc. (NYSE:PEN) by 69.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,540 shares of the company’s stock after purchasing an additional 1,450 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in Penumbra were worth $841,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. State Street Corp increased its position in Penumbra by 0.3% during the third quarter. State Street Corp now owns 1,236,671 shares of the company’s stock worth $240,298,000 after buying an additional 3,863 shares during the last quarter. Baillie Gifford & Co. boosted its stake in shares of Penumbra by 23.4% during the 4th quarter. Baillie Gifford & Co. now owns 730,233 shares of the company’s stock worth $173,416,000 after acquiring an additional 138,387 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Penumbra by 1.7% during the 3rd quarter. Geode Capital Management LLC now owns 655,572 shares of the company’s stock valued at $127,417,000 after acquiring an additional 11,257 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Penumbra by 8.2% in the 3rd quarter. Franklin Resources Inc. now owns 319,232 shares of the company’s stock valued at $67,473,000 after acquiring an additional 24,091 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Penumbra by 39.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 299,397 shares of the company’s stock worth $71,831,000 after purchasing an additional 85,284 shares during the last quarter. Institutional investors own 88.88% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on PEN shares. Bank of America assumed coverage on shares of Penumbra in a report on Friday, March 14th. They set a “buy” rating and a $320.00 price objective for the company. Wells Fargo & Company raised their price target on Penumbra from $275.00 to $305.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th. StockNews.com cut Penumbra from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Robert W. Baird lifted their price target on Penumbra from $305.00 to $328.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 19th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Penumbra in a research report on Wednesday, February 19th. Four analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $294.47.

Insider Buying and Selling at Penumbra

In related news, EVP Johanna Roberts sold 600 shares of Penumbra stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $287.43, for a total transaction of $172,458.00. Following the completion of the transaction, the executive vice president now directly owns 66,539 shares of the company’s stock, valued at $19,125,304.77. This trade represents a 0.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Adam Elsesser sold 61,600 shares of the company’s stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $283.59, for a total transaction of $17,469,144.00. Following the sale, the chief executive officer now directly owns 16,376 shares in the company, valued at $4,644,069.84. This represents a 79.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 111,236 shares of company stock worth $31,222,390 over the last three months. Company insiders own 5.00% of the company’s stock.

Penumbra Price Performance

Shares of Penumbra stock opened at $262.37 on Monday. Penumbra, Inc. has a twelve month low of $148.00 and a twelve month high of $310.00. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.25 and a current ratio of 6.01. The firm has a market cap of $10.11 billion, a P/E ratio of 771.66, a price-to-earnings-growth ratio of 2.83 and a beta of 0.56. The firm’s 50-day simple moving average is $274.48 and its 200-day simple moving average is $245.96.

Penumbra (NYSE:PEN) last released its quarterly earnings data on Tuesday, February 18th. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.88 by $0.09. Penumbra had a return on equity of 9.74% and a net margin of 1.17%. The company had revenue of $315.52 million for the quarter, compared to the consensus estimate of $311.63 million. As a group, research analysts expect that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.